Certara, Inc. Engages Investors in Upcoming Conferences
Certara, Inc. (Nasdaq: CERT), renowned for its pioneering role in model-informed drug development, is excited to connect with investors at a series of key upcoming conferences. These events provide an excellent platform for the company to showcase its innovative approaches and developments in the pharmaceutical industry.
Upcoming Investor Conferences
This year, management at Certara is set to participate in two notable investor conferences. The first is the BofA Securities 2025 Healthcare Conference. Scheduled for May 13, this conference will occur at 3:40 PM PT, and it promises to be an engaging opportunity for stakeholders to learn about Certara’s latest advancements and insights.
Key Details of the BofA Conference
The BofA Securities Healthcare Conference is known for gathering esteemed leaders and innovators from the healthcare sector. Attendance at this conference allows attendees to gain real-time insights into the strategies and innovations shaping the future of healthcare and drug development. Certara's presence signifies their commitment to transparency and investor relationships.
Exclusive Insights at the William Blair Conference
Following the BofA conference, Certara will also be featured at the William Blair 45th Annual Growth Stock Conference. This event is set for June 4, commencing at 12:40 PM CT. Like the previous event, this conference will allow Certara to share its strategic vision and groundbreaking technologies with a focused audience.
Streaming Webcasts
For those unable to attend in person, live webcasts of both conferences will be accessible on Certara's investor relations website. This presents a convenient opportunity for interested parties to engage with the content presented and gain valuable insights from the sessions. The webcasts will remain available for replay for a minimum of 90 days, ensuring that all stakeholders have the opportunity to catch up on what they may have missed.
About Certara, Inc.
As a leader in the field of biosimulation, Certara is at the forefront of transforming traditional drug discovery and development processes. Their innovative technologies and software solutions are employed by over 2,400 clients, including biopharmaceutical companies, academic institutions, and regulatory agencies in 66 countries around the globe. By leveraging these advanced tools, Certara accelerates the development of new medicines, demonstrating their commitment to enhancing healthcare outcomes.
Contact Information
For further inquiries, the Certara investor relations team can be contacted via David Deuchler, representing Gilmartin Group. Interested parties can reach out at ir@certara.com. For media inquiries, Alyssa Horowitz is available, and can be reached at certara@pancomm.com.
Frequently Asked Questions
What is Certara's focus area?
Certara specializes in model-informed drug development, focusing on biosimulation technologies and software to enhance the pharmaceutical process.
When is the BofA Securities 2025 Healthcare Conference?
The conference is scheduled for May 13 at 3:40 PM PT.
How can I access the conference webcasts?
Live webcasts will be available on Certara's investor relations website and will be accessible for replay for 90 days post-event.
What can attendees expect from the conferences?
Attendees can expect insights into Certara's innovations, market strategies, and discussions on the future of drug development.
Who should attend these conferences?
Investors, healthcare professionals, and stakeholders interested in the latest trends in pharmaceutical development should consider attending.
